We are live on
!
Find out more
VCAM
Valentine Capital Asset Management Portfolio holdings
AUM
$89.6M
1-Year Est. Return
0.84%
This Fund
S&P 500
This Quarter
Est. Return
-12.35%
1 Year Est. Return
-0.84%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
-$35.5M
(-24%)
Cap. Flow
-$15.9M
Cap. Flow
% of AUM
-14.08%
Top 10 Holdings %
Top 10 Hldgs %
30.62%
Holding
92
New
16
Increased
10
Reduced
51
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$2.56M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.97M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.94M |
| 4 |
Icahn Enterprises
IEP
|
+$1.73M |
| 5 |
Blackstone
BX
|
+$1.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AFSI
AmTrust Financial Services, Inc.
AFSI
|
+$2.82M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$2.75M |
| 3 |
ProShares Ultra Energy
DIG
|
+$2.75M |
| 4 |
Tractor Supply
TSCO
|
+$2.43M |
| 5 |
Direxion Daily MSCI Emerging Markets Bear 3X ETF
EDZ
|
+$1.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.68% |
| 2 | Consumer Discretionary | 11.33% |
| 3 | Technology | 8.71% |
| 4 | Communication Services | 7.37% |
| 5 | Energy | 6.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TARO
1
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $4.82M | 4.25% |
33,696
-9,647
| -22% | -$1.35M |
|
|
2
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $4.16M | 3.68% |
66,881
+25,061
| +60% | +$1.97M |
|
3
Direxion Daily Financial Bull 3x ETF
FAS
$2.44B
| $3.84M | 3.39% |
152,980
+12,837
| +9% | +$392K |
|
4
ProShares Ultra NASDAQ Biotechnology
BIB
$84.3M
| $3.47M | 3.07% |
59,623
+643
| +1% | +$54.8K |
|
|
IFN
5
Aberdeen India Fund
IFN
$501M
| $3.26M | 2.88% |
133,685
+5,256
| +4% | +$136K |
|
6
Jazz Pharmaceuticals
JAZZ
$16.2B
| $3.25M | 2.87% |
24,467
+2,227
| +10% | +$383K |
|
7
Ambarella
AMBA
$3.25B
| $3.02M | 2.67% |
52,299
+499
| +1% | +$47.1K |
|
8
B&G Foods
BGS
$293M
| $3.02M | 2.67% |
82,750
-28,025
| -25% | -$883K |
|
9
DexCom
DXCM
$28.8B
| $2.97M | 2.63% |
138,412
+41,952
| +43% | +$936K |
|
10
Direxion Daily MSCI India Bull 2X ETF
INDL
$56.7M
| $2.84M | 2.51% |
48,776
+16,688
| +52% | +$1.15M |
|
11
iShares China Large-Cap ETF
FXI
$4.37B
| $2.63M | 2.33% |
74,250
-24,105
| -25% | -$937K |
|
12
Omega Healthcare
OHI
$15.1B
| $2.62M | 2.32% |
74,575
-23,755
| -24% | -$834K |
|
|
13
AT&T
T
$159B
| $2.47M | 2.19% |
+100,507
| New | +$2.56M |
|
14
Expedia Group
EXPE
$35.2B
| $2.29M | 2.03% |
19,485
+2,147
| +12% | +$247K |
|
15
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.87B
| $2.16M | 1.91% |
21,355
-6,100
| -22% | -$725K |
|
16
Credit Suisse X-Links Gold Shares Covered Call ETNs due February 2 2033
GLDI
$31.3M
| $2.13M | 1.88% |
9,750
-2,867
| -23% | -$631K |
|
|
FL
17
DELISTED
Foot Locker
FL
| $2.07M | 1.83% |
28,819
-8,357
| -22% | -$595K |
|
18
Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033
SLVO
$11.5M
| $2.04M | 1.81% |
10,287
-3,093
| -23% | -$634K |
|
|
19
Icahn Enterprises
IEP
$5.18B
| $2.01M | 1.78% |
29,997
+23,010
| +329% | +$1.73M |
|
20
Walt Disney
DIS
$167B
| $1.96M | 1.73% |
19,200
-5,623
| -23% | -$612K |
|
21
iShares MSCI Hong Kong ETF
EWH
$1.25B
| $1.95M | 1.72% |
101,950
-29,290
| -22% | -$609K |
|
22
Under Armour
UAA
$2.91B
| $1.93M | 1.7% |
40,153
-13,203
| -25% | -$623K |
|
|
SVC
23
Service Properties Trust
SVC
$1.04B
| $1.9M | 1.68% |
14,954
-4,631
| -24% | -$627K |
|
|
24
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $1.8M | 1.59% |
+54,805
| New | +$1.94M |
|
25
Target
TGT
$65.6B
| $1.68M | 1.48% |
21,350
-6,600
| -24% | -$527K |
|
Similar funds
TSBJ
TP
SPC
DA
KCA
CCM
ST
HCM
Valentine Capital Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, Valentine Capital Asset Management held 92 positions worth $113M, down 24% from $149M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Valentine Capital Asset Management withdrew a net $15.9M in Q3 2015, closing 15 positions and reducing 51 holdings. Its most notable exit was AmTrust Financial Services, Inc., an estimated $2.82M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Valentine Capital Asset Management opened a new position in AT&T worth $2.47M.
- Valentine Capital Asset Management's largest Q3 2015 buy was AT&T: 100,507 shares worth $2.47M.
- Valentine Capital Asset Management added most to State Street SPDR S&P Biotech ETF in Q3 2015, an estimated $1.97M increase.
- Valentine Capital Asset Management's biggest Q3 2015 reduction was Chevron, cutting an estimated $1.49M.
- Valentine Capital Asset Management fully exited AmTrust Financial Services, Inc. in Q3 2015, selling an estimated $2.82M.
- Valentine Capital Asset Management's ten largest holdings make up 31% of its $113M portfolio in Q3 2015.
- Valentine Capital Asset Management opened 16 new positions and closed 15 in Q3 2015.
- Valentine Capital Asset Management's portfolio value fell 24% quarter-over-quarter to $113M.
Based on Valentine Capital Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.